Agios Pharmaceuticals Ownership | Who Owns Agios Pharmaceuticals?
Agios Pharmaceuticals Ownership Summary
Agios Pharmaceuticals is owned by 106.42% institutional investors, 1.68% insiders. Farallon capital management is the largest institutional shareholder, holding 9.98% of AGIO shares. BB Biotech AG Ord is the top mutual fund, with 6.16% of its assets in Agios Pharmaceuticals shares.
AGIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Agios Pharmaceuticals | 106.42% | 1.68% | -8.11% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Farallon capital management | 5.78M | 9.98% | $232.05M |
| Vanguard group | 5.60M | 9.67% | $224.98M |
| Blackrock | 4.86M | 8.55% | $209.52M |
| Blackrock funding, inc. /de | 4.55M | 7.85% | $182.47M |
| Bellevue group | 3.71M | 6.41% | $149.11M |
| Erste asset management gmbh | 2.76M | 4.77% | $108.58M |
| Paradigm biocapital advisors lp | 2.67M | 4.61% | $107.32M |
| Wellington management group llp | 2.47M | 4.27% | $99.20M |
| Commodore capital lp | 2.34M | 4.04% | $93.86M |
| State street | 2.26M | 3.91% | $90.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caligan partners lp | 1.13M | 5.95% | $45.41M |
| Commodore capital lp | 2.34M | 4.58% | $93.86M |
| Cutter capital management, lp | 301.62K | 4.06% | $9.91M |
| Bellevue group | 3.71M | 3.10% | $149.11M |
| Paradigm biocapital advisors lp | 2.67M | 3.05% | $107.32M |
| Tcg crossover management | 1.43M | 2.82% | $57.40M |
| Eagle health investments lp | 246.23K | 2.59% | $9.88M |
| Rock springs capital management lp | 958.54K | 2.25% | $38.48M |
| Palo alto investors lp | 265.50K | 1.97% | $10.66M |
| Highvista strategies | 195.30K | 1.92% | $7.84M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 2.47M | 0.02% | 2.05M |
| Paradigm biocapital advisors lp | 2.67M | 3.05% | 1.53M |
| Tcg crossover management | 1.43M | 2.82% | 733.04K |
| Erste asset management gmbh | 2.76M | 1.05% | 438.41K |
| Jane street group | 395.12K | 0.00% | 361.63K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jefferies financial group | - | - | -1.50M |
| Bvf inc/il | - | - | -1.07M |
| Polar capital | - | - | -1.00M |
| T. rowe price investment management | - | - | -928.60K |
| Jpmorgan chase | 183.10K | 0.00% | -844.32K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Axa investment managers | 177.68K | 0.02% | 177.68K | $7.13M |
| Peregrine capital management | 162.91K | 0.20% | 162.91K | $6.54M |
| Alyeska investment group | 146.51K | 0.02% | 146.51K | $5.88M |
| Norges bank | 145.09K | 0.00% | 145.09K | $4.77M |
| Vestal point capital, lp | 127.00K | 0.23% | 127.00K | $5.10M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Global financial private client | -3.00 |
| Ifp advisors | -3.00 |
| Riggs asset managment | -3.00 |
| Southstate | -4.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 217 | -3.56% | 61,654,515 | 3.33% | 106 | 0.99% | 108 | -5.26% | 76 | 5.56% |
| Mar 31, 2025 | 223 | -4.29% | 59,949,912 | 0.23% | 104 | 0.95% | 113 | -12.40% | 71 | 2.90% |
| Dec 31, 2024 | 231 | 4.05% | 58,738,591 | 1.40% | 103 | 1.00% | 126 | 22.33% | 70 | 2.94% |
| Sep 30, 2024 | 222 | 1.83% | 57,925,704 | 3.66% | 101 | 1.05% | 104 | 1.96% | 66 | -15.38% |
| Jun 30, 2024 | 218 | 9.00% | 55,883,066 | -6.01% | 98 | 0.88% | 102 | -0.97% | 78 | 39.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 3.52M | 6.16% | -220.76K |
| Vanguard US Total Market Shares ETF | 1.79M | 3.12% | 2.35K |
| Vanguard Total Stock Mkt Idx Inv | 1.81M | 3.11% | -38.53K |
| Macquarie Small Cap Core I | 1.43M | 2.46% | -107.41K |
| Delaware Small Cap Core I | 1.38M | 2.42% | -8.55K |
| Vanguard Small Cap Index | 1.41M | 2.42% | -9.02K |
| iShares Russell 2000 ETF | 1.36M | 2.34% | - |
| Polar Capital Biotech S Inc | 1.00M | 1.73% | - |
| T. Rowe Price Health Sciences | 979.66K | 1.69% | -10.99K |
| DWS Vermögensbildungsfonds I LD | 805.52K | 1.39% | 3.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 12, 2025 | Scadden David | - | Sell | $8.77K |
| Nov 11, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | $107.44K |
| Oct 30, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | $8.76K |
| Oct 27, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | $145.02K |
| Oct 08, 2025 | Scadden David | - | Sell | $8.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 9 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 16 |
| 2024 Q4 | - | 9 |
AGIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools